ROCKVILLE, Md., Jan. 01, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ:MXCT, LSE: MXCT))), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative bioprocessing applications, is pleased to confirm the appointment of Maher Masoud as President and Chief Executive Officer of MaxCyte effective as of January 1, 2024. In addition, Mr. Masoud now serves as a director on Max ...

MaxCyte, Inc. (NASDAQ:MXCT) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Sean Menarguez - Head of IR Doug Doerfler - President & CEO Douglas Swirsky - CFO Conference Call Participants Dan Arias - Stiefel Hannah Hefley - Stephens Matt Larew - William Blair Steven Mah - TD Cowen Operator Good day, and thank you for standing by, and welcome to MaxCyte’s Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' pres ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the transition period from___ to___ Commission file number: 001-40674 MaxCyte, Inc. (Exact name of registrant as specified in its charter) FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Indicate by check mark w ...

MaxCyte, Inc. (NASDAQ:MXCT) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Sean Menarguez - Head-IR Doug Doerfler - President and CEO Douglas Swirsky - CFO Conference Call Participants Julie Simmonds - Panmure Gordon Dan Arias - Stiefel Jacob Johnson - Stephens Madeline Mollman - William Blair Vidyun Bais - BTIG Steven Mah - TD Cowen Operator Thank you for standing by, and welcome to MaxCyte's Second Quarter 2023 Earnings Call. At this time, all participants are in a listen- ...

Table of Contents Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from___ to___ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Commission file number: 001-40674 MaxCyte, Inc. (Exact name of registrant as specified in its charter) Delaware 52-2210438 (State or ...

MaxCyte, Inc. (NASDAQ:MXCT) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Sean Menarguez - Head-Investor Relations Doug Doerfler - President & Chief Executive Officer Douglas Swirsky - Chief Financial Office Conference Call Participants Julie Simmonds - Panmure Gordon Dan Arias - Stifel Hannah Hefley - Stephens Steven Mah - TD Cowen Madeline Mollman - William Blair Vidyun Bais - BTIG Operator Good day, and thank you for standing by and welcome to MaxCyte’s First Quarter Earn ...

Disclaimer Certain statements in this Presentation are, or may be deemed to be, forward looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1955, including but not limited to statements regarding our expected potential future revenue. The words "may," "might," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "expect," "estimate," "seek," "predict," "future," "project," "potential," "continue," "targe ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from___ to___ Commission file number: 001-40674 MaxCyte, Inc. (Exact name of registrant as specified in its charter) Delaware 52-2210438 (State o ...

Disclaimer This presentation is only addressed to and directed at (i) persons who are outside the United Kingdom, (ii) persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), (iii) persons who are high net worth entities falling within Article 49(2)(a) to (d) of the Order, and/or (iv) any other persons to whom this presentation may otherwise lawfully be ...

MaxCyte, Inc. (NASDAQ:MXCT) Q4 2022 Earnings Conference Call March 15, 2023 4:30 PM ET Company Participants Sean Menarguez - Investor Relations Doug Doerfler - President and Chief Executive Officer Ron Holtz - Interim Chief Financial Officer Conference Call Participants Julie Simmonds - Panmure Gordon Dan Arias - Stifel Matt Larew - William Blair Jacob Johnson - Stephens Vidyun Bais - BTIG Operator Good day and thank you for standing by and welcome to MaxCyte’s Fourth Quarter Earnings Conference Call. [Oper ...